Lincoln Pharmaceuticals Ltd. - Research Center

---

Results

• Quarterly
• Half yearly
• Annual

Statement

• Balance sheet
• P&L
• Cash flow

More

• Dividend
• Share holding
• Capital structures
• Ratio

Jun' 24	Mar' 24	Dec' 23	Sep' 23	Jun' 23

Sales

147.28

142.49

146.45

155.99

135.62

Operating profit

22.73

18.38

29.66

31.15

20.72

Interest

0.44

0.50

0.15

0.39

0.41

Gross profit

32.70

24.90

40.52

39.45

27.99

EPS (Rs)

11.82

9.28

14.00

13.81

9.49

Other income

10.41

7.02

11.02

8.69

7.69

Stock adjustment

4.16

4.69

-20.30

4.20

5.71

Raw material

52.75

51.89

56.88

49.66

42.70

Power and fuel

-

-

-

-

-

Employee expenses

29.02

25.05

26.44

24.94

26.47

Excise

-

-

-

-

-

Admin and selling expenses

-

-

-

-

-

Research and development expenses

-

-

-

-

-

Expenses capitalised

-

-

-

-

-

Other expenses

38.62

42.48

53.77

46.03

40.03

Provisions made

-

-

-

-

-

Depreciation

3.22

2.69

2.81

2.58

2.55

Taxation

5.81

3.62

9.67

9.21

6.43

Net profit / loss

23.67

18.60

28.04

27.65

19.01

Extra ordinary item

-

-

-

-

-

Prior year adjustments

-

-

-

-

-

Equity capital

20.03

20.03

20.03

20.03

20.03

Equity dividend rate

-

-

-

-

-

Agg.of non-prom. shares (Lacs)

-

-

-

-

-

Agg.of non promotoholding (%)

-

-

-

-

-

OPM (%)

15.43

12.90

20.25

19.97

15.27

GPM (%)

20.74

16.66

25.73

23.95

19.53

NPM (%)

15.01

12.44

17.81

16.79

13.27